Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.

Biocytogen has entered a strategic partnership with Sihuan Pharmaceutical to advance new therapeutics across several disease areas.

Lilly will hope Foundayo continues its growing dominance over Novo Nordisk in the obesity drug market. Credit: Michael Vi/Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli ...

GlobalData anticipates notable growth in the head and neck squamous cell carcinoma (HNSCC) market by 2034, at a CAGR of 8.4%.

Novo Nordisk has received FDA approval for Awiqli injection 700 units/mL, a basal insulin for adults with type 2 diabetes.

A lack of effective non-invasive ways to diagnose endometriosis contributes to delayed intervention and limits the potential for clinical development of therapeutics. Credit: H_Ko/Shutterstock.com.

Telomir Pharmaceuticals has submitted an IND application to the FDA for Telomir-1, its lead candidate targeting advanced and metastatic TNBC.

Otsuka Pharmaceutical is to fully acquire Transcend Therapeutics via its subsidiary Otsuka America for a potential ...

Eli Lilly and Insilico Medicines' AI-centric collaboration further deepens relations between the two companies, which began ...

As ADC pipelines expand rapidly, innovations in payload linker chemistry are becoming a key enabler of next-generation ...

GlobalData analysed the product launch and withdrawal trends using its POLI database, comparing activity in the ten months ...